ACAD - ACADIA Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACAD is currently covered by 21 analysts with an average price target of $30.34. This is a potential upside of $6.3 (26.21%) from yesterday's end of day stock price of $24.04.

ACADIA Pharmaceuticals's activity chart (see below) currently has 393 price targets and 323 ratings on display. The stock rating distribution of ACAD is 31.76% HOLD and 68.24% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 65.9% with an average time for these price targets to be met of 225.53 days.

Highest price target for ACAD is $37, Lowest price target is $20, average price target is $28.11.

Most recent stock forecast was given by TESSA ROMERO from JPMORGAN on 24-Jul-2025. First documented stock forecast 06-May-2013.

Currently out of the existing stock ratings of ACAD, 27 are a HOLD (31.76%), 58 are a BUY (68.24%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$34

$10.17 (42.68%)

$30

11 days ago
(24-Jul-2025)

5/10 (50%)

$10.95 (47.51%)

26

Buy

$37

$13.17 (55.27%)

$42

1 months 9 days ago
(26-Jun-2025)

9/16 (56.25%)

$14.79 (66.59%)

238

Buy

$32

$8.17 (34.28%)

$32

1 months 9 days ago
(26-Jun-2025)

7/23 (30.43%)

$9.79 (44.08%)

118

Buy

$30

$6.17 (25.89%)

$30

1 months 9 days ago
(26-Jun-2025)

0/9 (0%)

$7.79 (35.07%)

Hold

$22

$-1.83 (-7.68%)

$19

1 months 9 days ago
(26-Jun-2025)

16/16 (100%)

$-0.21 (-0.95%)

89

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACAD (ACADIA Pharmaceuticals) average time for price targets to be met?

On average it took 225.53 days on average for the stock forecasts to be realized with a an average price target met ratio 65.9

Which analyst has the current highest performing score on ACAD (ACADIA Pharmaceuticals) with a proven track record?

CORY KASIMOV

Which analyst has the most public recommendations on ACAD (ACADIA Pharmaceuticals)?

Cory Kasimov works at EVERCORE and has 8 price targets and 6 ratings on ACAD

Which analyst is the currently most bullish on ACAD (ACADIA Pharmaceuticals)?

Alan Carr with highest potential upside - $36.17

Which analyst is the currently most reserved on ACAD (ACADIA Pharmaceuticals)?

Salveen Richter with lowest potential downside - -$11.83

ACADIA Pharmaceuticals in the News

High Growth US Tech Stocks To Watch In August 2025

As of July 2025, the U.S. stock market has experienced a mixed performance with major indices like the S&P 500 and Nasdaq reaching record highs earlier in the month, despite recent declines amid fluctuating investor sentiment driven by tech earnings and economic data. In this environment, identifying high-growth tech stocks requires a focus on companies...

Exploring US High Growth Tech Stocks For July 2025

As the U.S. stock market continues to show resilience with major indices like the S&P 500 and Nasdaq hitting record highs, driven by strong corporate earnings and a steady economic environment, investors are closely watching developments in the tech sector. In this landscape of optimism and robust performance, identifying high-growth tech stocks involves looking for...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?